9-[(1S,6S,10S,15R)-3,12-dihydroxy-3,12-dioxo-17-(6-oxo-1H-purin-9-yl)-2,4,7,13,16-pentaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one

C21H24N8O11P2 — CID 137292819

IUPAC9-[(1S,6S,10S,15R)-3,12-dihydroxy-3,12-dioxo-17-(6-oxo-1H-purin-9-yl)-2,4,7,13,16-pentaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one
SMILESO=c1[nH]cnc2c1ncn2C1C[C@@H]2CP(=O)(O)OC[C@H]3OC(n4cnc5c(=O)[nH]cnc54)C[C@@H]3OP(=O)(O)OC[C@H]2O1
InChIInChI=1S/C21H24N8O11P2/c30-20-16-18(22-6-24-20)28(8-26-16)14-1-10-5-41(32,33)36-4-13-11(40-42(34,35)37-3-12(10)38-14)2-15(39-13)29-9-27-17-19(29)23-7-25-21(17)31/h6-15H,1-5H2,(H,32,33)(H,34,35)(H,22,24,30)(H,23,25,31)/t10-,11+,12-,13-,14?,15?/m1/s1
InChIKeySRSXNGQSHJYUFP-KMGHYOBBSA-N
MW626.42 g/mol
LogP0.16
Rot. Bonds2

About 9-[(1S,6S,10S,15R)-3,12-dihydroxy-3,12-dioxo-17-(6-oxo-1H-purin-9-yl)-2,4,7,13,16-pentaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one

9-[(1S,6S,10S,15R)-3,12-dihydroxy-3,12-dioxo-17-(6-oxo-1H-purin-9-yl)-2,4,7,13,16-pentaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one (PubChem CID 137292819) has the molecular formula C21H24N8O11P2 and a molecular weight of 626.42 g/mol. Its IUPAC name is 9-[(1S,6S,10S,15R)-3,12-dihydroxy-3,12-dioxo-17-(6-oxo-1H-purin-9-yl)-2,4,7,13,16-pentaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one.

Molecular Properties

Compound Name9-[(1S,6S,10S,15R)-3,12-dihydroxy-3,12-dioxo-17-(6-oxo-1H-purin-9-yl)-2,4,7,13,16-pentaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one
PubChem CID137292819
Molecular FormulaC21H24N8O11P2
Molecular Weight626.42 g/mol
Exact Mass626.10
IUPAC Name9-[(1S,6S,10S,15R)-3,12-dihydroxy-3,12-dioxo-17-(6-oxo-1H-purin-9-yl)-2,4,7,13,16-pentaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one
SMILESO=c1[nH]cnc2c1ncn2C1C[C@@H]2CP(=O)(O)OC[C@H]3OC(n4cnc5c(=O)[nH]cnc54)C[C@@H]3OP(=O)(O)OC[C@H]2O1
InChIInChI=1S/C21H24N8O11P2/c30-20-16-18(22-6-24-20)28(8-26-16)14-1-10-5-41(32,33)36-4-13-11(40-42(34,35)37-3-12(10)38-14)2-15(39-13)29-9-27-17-19(29)23-7-25-21(17)31/h6-15H,1-5H2,(H,32,33)(H,34,35)(H,22,24,30)(H,23,25,31)/t10-,11+,12-,13-,14?,15?/m1/s1
InChIKeySRSXNGQSHJYUFP-KMGHYOBBSA-N
XLogP0.16
TPSA247.89 Ų
H-Bond Donors4
H-Bond Acceptors15
Rotatable Bonds2
Heavy Atoms42
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500626.42
LogP ≤ 50.16
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze 9-[(1S,6S,10S,15R)-3,12-dihydroxy-3,12-dioxo-17-(6-oxo-1H-purin-9-yl)-2,4,7,13,16-pentaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-amino-9-[(1R,6S,8R,10R,15R,17R)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one
CID 135961756
2-amino-9-[(4S,6R,8S,13R,14R)-11-hydroxy-11-oxo-6-(6-oxo-1H-purin-9-yl)-7,10,12,15-tetraoxa-11λ5-phosphatricyclo[11.2.1.04,8]hexadecan-14-yl]-1H-purin-6-one
CID 137149449
9-[(1S,10S)-17-(6-amino-2-chloropurin-9-yl)-3,12-dihydroxy-12-oxo-2,4,7,11,13,16-hexaoxa-3,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one
CID 138751048
9-[(4aR,6R,7R,7aS)-2,7-dihydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-(2,3,4,5-13C4)furano[3,2-d](4,5,6-13C3)[1,3,2]dioxaphosphinin-6-yl]-1H-purin-6-one
CID 171381580
9-[4-(hydroxymethyl)oxetan-2-yl]-1H-purin-6-one
CID 135856505
9-[(2R,4S)-4-(hydroxymethyl)oxetan-2-yl]-1H-purin-6-one
CID 135508917
9-[(1S,6R,8R,9R,10R,15R,17R)-17-(6-aminopurin-9-yl)-9-fluoro-3,12-dihydroxy-12-oxo-3-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one
CID 148776797
2-amino-9-[(5R,7R)-12,17-dihydroxy-12-oxo-7-(6-oxo-1H-purin-9-yl)-2,4,8,11,13,16-hexaoxa-12λ5-phosphatricyclo[12.2.1.05,9]heptadecan-15-yl]-1H-purin-6-one
CID 137149351
2-amino-9-[(6R,8R,15R,17R,18S)-17-(2-amino-6-oxo-1H-purin-9-yl)-3,12,18-trihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one
CID 136602236
9-[(1R,9R,10R,18R)-17-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;9-[(1R,9R,10R,18R)-17-(6-aminopurin-9-yl)-9,18-difluoro-12-hydroxy-3-oxo-3-sulfanyl-12-sulfanylidene-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one;9-[(1S,9R,10R)-17-(6-aminopurin-9-yl)-9-fluoro-3,12-dihydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one
CID 158831247
2-amino-9-[(6R,8R,15R,17R)-8-(6-aminopurin-9-yl)-3,12,18-trihydroxy-3,12-dioxo-2,4,7,11,13-pentaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-17-yl]-1H-purin-6-one
CID 174009304
9-[(6R,8R,15R,17R)-8-(benzimidazol-1-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one
CID 147807273

Frequently Asked Questions

What is the IUPAC name of 9-[(1S,6S,10S,15R)-3,12-dihydroxy-3,12-dioxo-17-(6-oxo-1H-purin-9-yl)-2,4,7,13,16-pentaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one?
The IUPAC name of 9-[(1S,6S,10S,15R)-3,12-dihydroxy-3,12-dioxo-17-(6-oxo-1H-purin-9-yl)-2,4,7,13,16-pentaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one (CID 137292819) is 9-[(1S,6S,10S,15R)-3,12-dihydroxy-3,12-dioxo-17-(6-oxo-1H-purin-9-yl)-2,4,7,13,16-pentaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one.
What is the SMILES notation for 9-[(1S,6S,10S,15R)-3,12-dihydroxy-3,12-dioxo-17-(6-oxo-1H-purin-9-yl)-2,4,7,13,16-pentaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one?
The canonical SMILES for 9-[(1S,6S,10S,15R)-3,12-dihydroxy-3,12-dioxo-17-(6-oxo-1H-purin-9-yl)-2,4,7,13,16-pentaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one is O=c1[nH]cnc2c1ncn2C1C[C@@H]2CP(=O)(O)OC[C@H]3OC(n4cnc5c(=O)[nH]cnc54)C[C@@H]3OP(=O)(O)OC[C@H]2O1.
What is the InChIKey of 9-[(1S,6S,10S,15R)-3,12-dihydroxy-3,12-dioxo-17-(6-oxo-1H-purin-9-yl)-2,4,7,13,16-pentaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one?
The InChIKey is SRSXNGQSHJYUFP-KMGHYOBBSA-N. The full InChI is InChI=1S/C21H24N8O11P2/c30-20-16-18(22-6-24-20)28(8-26-16)14-1-10-5-41(32,33)36-4-13-11(40-42(34,35)37-3-12(10)38-14)2-15(39-13)29-9-27-17-19(29)23-7-25-21(17)31/h6-15H,1-5H2,(H,32,33)(H,34,35)(H,22,24,30)(H,23,25,31)/t10-,11+,12-,13-,14?,15?/m1/s1.
What are the key properties of 9-[(1S,6S,10S,15R)-3,12-dihydroxy-3,12-dioxo-17-(6-oxo-1H-purin-9-yl)-2,4,7,13,16-pentaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one?
9-[(1S,6S,10S,15R)-3,12-dihydroxy-3,12-dioxo-17-(6-oxo-1H-purin-9-yl)-2,4,7,13,16-pentaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one has a molecular weight of 626.42 g/mol, XLogP of 0.16, 2 rotatable bonds, 4 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 9-[(1S,6S,10S,15R)-3,12-dihydroxy-3,12-dioxo-17-(6-oxo-1H-purin-9-yl)-2,4,7,13,16-pentaoxa-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one is sourced from PubChem (CID 137292819), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).